[Usefulness of 2-component human fibrin glue in stabilizing vascular sutures at risk in hemodialysis]

The controversies arising in recent years over the possible transmission of viruses including the hepatitis and HTLV III type in blood derivatives that have been more or less purified or screened for specific antibodies are still to be fully resolved. Though some statistical epidemiological studies seem to exclude the possibility when it comes to the use of bicomponent human fibrin glue (Tissucol) (Eder et al., 1986) it seems unreasonable totally to exclude the possibility of contamination arising from the use of this product. Certainly such contamination is only a remote possibility in haemodialysis patients who, obliged by their condition to undergo repeated intravascular injections of blood or other blood derivates, are highly unlikely to contract disease precisely due to the use of fibrin glue. For this reason, over the past three years bicomponent human fibrin glue has been used whenever necessary and has proved extremely valuable in stabilising vascular sutures at risk.